$CADX Company News U.S. stock benchmarks rally from

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2013 at 9:57 AM

$CADX Company News

U.S. stock benchmarks rally from obvious support 9:51 a.m. June 10, 2013 - Michael Ashbaugh
Cadence falls on analyst downgrade 2:40 p.m. Aug. 30, 2012 - Val Brickates Kennedy
Stocks to watch Wednesday: AT&T, AES, Deere 6:54 a.m. Nov. 23, 2011 - MarketWatch
Cadence Pharmaceuticals down 5.3% 12:01 p.m. Nov. 15, 2011 - David B. Wilkerson
Cadence Pharma plans to sell $75 mln in stock 8:05 a.m. Nov. 14, 2011 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:44 p.m. March 4, 2011 - Kate Gibson
Wednesday’s biggest gaining and declining stocks 3:32 p.m. Nov. 3, 2010 - Kate Gibson
Drug indexes flat as Lundbeck slides 12:09 p.m. Nov. 3, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 3:52 p.m. April 19, 2010 - MarketWatch
Cadence jumps, Lilly slips in afternoon trading 12:51 p.m. April 19, 2010 - Val Brickates Kennedy
In focus: At the highs 6:42 p.m. Nov. 11, 2009 - Lawrence G. McMillan
Cadence Pharma starts at buy at Pacific Growth 10:57 a.m. Dec. 4, 2006 - Leslie Wines
Merrill sets Cadence Pharma price target at $16 9:21 a.m. Dec. 4, 2006 - Tomi Kilgore
Cadence Pharma started at buy at Merrill Lynch 9:21 a.m. Dec. 4, 2006 - Tomi Kilgore
Cadence Pharma IPO rises after price cut 10:39 a.m. Oct. 25, 2006 - Steve Gelsi
Cadence Pharma prices IPO of 6M shares at $9 each 7:56 a.m. Oct. 25, 2006 - Thomas Middleton

Cadence: Best Case Outcome On Ofirmev Patent Litigation 9:35 a.m. Nov. 15, 2013 - Seeking Alpha
Cadence Pharmaceuticals Announces Favorable Court Ruling In OFIRMEV Patent Litigation 5:58 p.m. Nov. 14, 2013 - benzinga.com
Cadence Pharma Reports In-Line Loss, Beats Rev - Analyst Blog 11:50 a.m. Nov. 7, 2013 - Zacks.com
10-Q: CADENCE PHARMACEUTICALS INC 4:41 p.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cadence Pharmaceuticals: Ofirmev Launch A Spectacular Success, But Investors Focused On Patent Litigation 1:42 p.m. Nov. 6, 2013 - Seeking Alpha
Cadence Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 8:33 p.m. Nov. 5, 2013 - Seeking Alpha
Cadence Pharma's Ofirmev Gets Black Box - Analyst Blog 11:10 a.m. Oct. 21, 2013 - Zacks.com
Cadence: Comments On Patent Office Re-Examination Of Key Cadence Patent 1:46 p.m. Aug. 16, 2013 - Seeking Alpha
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent, Says Patents On OFIRMEV Are Valid Until Final Ruling 3:22 p.m. Aug. 15, 2013 - benzinga.com
Cadence: Ofirmev Sales Are Very Strong; Patent Decision Could Come By Year-End 6:10 p.m. Aug. 2, 2013 - Seeking Alpha
10-Q: CADENCE PHARMACEUTICALS INC 3:15 p.m. Aug. 2, 2013 - Edgar Online - (EDG = 10Q, 10K)
Wider Loss at CADX in Q2 - Analyst Blog 11:58 a.m. Aug. 1, 2013 - Zacks.com
Cadence Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript 7:35 p.m. July 31, 2013 - Seeking Alpha
Wider 2Q Loss at ArQule - Analyst Blog 4:00 p.m. July 31, 2013 - Zacks.com
Cadence Pharmaceuticals Inc. (CADX) Management Discusses Q2 2013 Results (Webcast) 3:34 p.m. July 31, 2013 - Seeking Alpha
Narrower-Than-Expected Loss at BioMarin - Analyst Blog 3:45 p.m. July 26, 2013 - Zacks.com
Earnings Beat at Warner Chilcott - Analyst Blog 12:10 p.m. July 25, 2013 - Zacks.com
Glaxo Revs Up, Earnings Down - Analyst Blog 11:10 a.m. July 25, 2013 - Zacks.com
Pipeline Progress at XOMA - Analyst Blog 4:20 p.m. July 24, 2013 - Zacks.com
TTHI, Eli Lilly Ink Deal - Analyst Blog 4:00 p.m. July 24, 2013 - Zacks.com

Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation 6:54 p.m. Nov. 14, 2013 - PR Newswire
Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback 3:00 p.m. Nov. 8, 2013 - PR Newswire
Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:00 p.m. Nov. 5, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013 3:00 p.m. Oct. 29, 2013 - PR Newswire
Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013 3:00 p.m. Sept. 4, 2013 - PR Newswire
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent 4:17 p.m. Aug. 15, 2013 - PR Newswire
Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors 7:30 a.m. Aug. 15, 2013 - PR Newswire
Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013 4:45 p.m. Aug. 6, 2013 - PR Newswire
Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results 3:00 p.m. July 31, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013 3:00 p.m. July 24, 2013 - PR Newswire
Cadence Pharmaceuticals To Present At The 8th Annual JMP Securities Healthcare Conference On July 9, 2013 5:00 p.m. July 2, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ANGI, CADX, FMER and MKTG 7:33 a.m. June 24, 2013 - ACCESSWIRE
Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013 3:00 p.m. May 8, 2013 - PR Newswire
Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results 3:00 p.m. May 2, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013 3:00 p.m. April 25, 2013 - PR Newswire
Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors 3:00 p.m. March 14, 2013 - PR Newswire
Cadence Pharmaceuticals Announces the Availability of OFIRMEV® (acetaminophen) Injection through the VA National Formulary 7:00 a.m. March 12, 2013 - PR Newswire
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results 7:30 a.m. March 7, 2013 - PR Newswire
Cadence Pharmaceuticals Announces Strategic Plan to Secure Long-Term Manufacture and Supply of OFIRMEV? (acetaminophen) Injection 8:23 p.m. March 6, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013 4:15 p.m. Feb. 28, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chiropractic Insights: Differentiating Piriformis vs. Disc Pain

Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...

Decoding LRV: Smart Paint Choices for Your Home

Unraveling the Secrets of LRV Nobody thought analyzing paint meant diving into light reflectance values (LRV), but that's precisely where we're headed today. Painting a room seems simple until you realize your color choice might turn your bright haven into a cave or vice versa. Thanks to some insights from Wendy Anguiano in HelloNation, let's dig into this technical...

OlloBot's Emotional AI Robots Connect Beyond Tasks

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

New Era Celebrates Valkyries' Groundbreaking WNBA Win

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Decoding Real Estate Value: A Market Insider's Take

Riding the Waves of Real Estate Pricing Homeowners dipping their toes into the real estate market know that setting the right price ain't a walk in the park. Luckily, Matt Nuzie, Shelton's real estate pro, has peeled back the layers on comparative market analyses (CMA) in a HelloNation piece. This isn't just about tossing a number out there—it's about understanding the...

Gildan Faces Class Action Deadline Over Fraud Claims

Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...

Ensuring Flooring Stability: Acclimation's Key Role

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Knob-and-Tube Wiring: A Hidden Hazard Unveiled

Unlocking the Mysteries of Knob-and-Tube Wiring Ever wondered if the wiring in your charming hundred-year-old home might be a ticking time bomb? Welcome to the world of knob-and-tube wiring. This blast from the past might just be hiding in those walls and could spell trouble. The History and Hazards of Knob-and-Tube This wiring system dates back to the 1880s, sticking...

Bahrain's USD 3.89 Billion Investment Surge in 2026

Bahrain's Bold Moves to Woo Global Investment Bahrain's never been one to tiptoe around, huh? With a whopping USD 3.89 billion on the line, the Kingdom's flashing its neon sign to investors: "Open for Business!" These Golden License projects aren't just a few shiny new ventures — they're bridging aviation logistics, real estate, and the tech sector. Talk about ambition....

Langford Chosen for Navy Mutual's 2026 Bolles Award

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...